International Stem Cell Co. (OTCMKTS:ISCO – Get Free Report) shares crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $0.08 and traded as high as $0.11. International Stem Cell shares last traded at $0.11, with a volume of 3,725 shares changing hands.
International Stem Cell Stock Down 16.3 %
The business’s 50 day simple moving average is $0.10 and its 200-day simple moving average is $0.08.
About International Stem Cell
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.
Recommended Stories
- Five stocks we like better than International Stem Cell
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Oracle Announces Game-Changing News for the AI Industry
- 3 Tickers Leading a Meme Stock Revival
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- Which Wall Street Analysts are the Most Accurate?
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.
